发明名称 |
Beta2 microglobulin fusion proteins and high affinity variants |
摘要 |
beta 2-microglobulin fusion proteins and modified forms of beta 2-microglobulin are disclosed. The fusion proteins are shown to incorporate onto the surface of MHC I expressing mammalian cells and to cause an increased cytotoxic T-cell response to antigens presented by such cells. The fusion proteins are useful in methods of tumor therapy. Modified forms of human beta 2-microglobulin, particularly a form having a serine to valine transition at amino acid position 55 of the mature protein are shown to have an enhanced affinity for MHC I heavy chain, and are useful both in the disclosed fusion proteins and as a vaccine adjuvant where enhanced cytotoxic T-cell response is desired. |
申请公布号 |
AU4545799(A) |
申请公布日期 |
1999.12.30 |
申请号 |
AU19990045457 |
申请日期 |
1999.06.03 |
申请人 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY |
发明人 |
RANDALL K. RIBAUDO;MICHAEL SHIELDS |
分类号 |
A61K38/00;A61K39/39;C07K14/705;C07K14/74;C12N15/13 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|